| Literature DB >> 28058511 |
Roberta La Piana1,2, Woranontee Weraarpachai3,4, Luis H Ospina5, Martine Tetreault6, Jacek Majewski6, G Bruce Pike7, Jean-Claude Decarie8, Donatella Tampieri2, Bernard Brais1,3, Eric A Shoubridge9,10.
Abstract
Mitochondrial protein synthesis is initiated by formylated tRNA-methionine, which requires the activity of MTFMT, a methionyl-tRNA formyltransferase. Mutations in MTFMT have been associated with Leigh syndrome, early-onset mitochondrial leukoencephalopathy, microcephaly, ataxia, and cardiomyopathy. We identified compound heterozygous MTFMT mutations in a patient with a mild neurological phenotype and late-onset progressive visual impairment. MRI studies documented a progressive and selective involvement of the retrochiasmatic visual pathway. MTFMT was undetectable by immunoblot analysis of patient fibroblasts, resulting in specific defects in mitochondrial protein synthesis and assembly of the oxidative phosphorylation complexes. This report expands the clinical and MRI phenotypes associated with MTFMT mutations, illustrating the complexity of genotype-phenotype relationships in mitochondrial translation disorders.Entities:
Keywords: Leukoencephalopathy; MTFMT; OXPHOS defects; Optic pathway; Whole exome sequencing
Mesh:
Substances:
Year: 2017 PMID: 28058511 DOI: 10.1007/s10048-016-0506-0
Source DB: PubMed Journal: Neurogenetics ISSN: 1364-6745 Impact factor: 2.660